Driehaus Capital Management

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Driehaus Capital Management's primary investment focus?

Driehaus Capital Management primarily focuses on the Health Tech & Life Sciences sector, with all its portfolio companies and investment rounds concentrated in this area.

When did Driehaus Capital Management make its first recorded investment?

Driehaus Capital Management made its first recorded investment in January 2021.

What is the typical investment range for Driehaus Capital Management?

Driehaus Capital Management's investment range is between $70M and $100M per round.

Can you name a notable portfolio company of Driehaus Capital Management?

A notable portfolio company of Driehaus Capital Management is C2i Genomics, which raised $100M in April 2021. Another is DarioHealth, which raised $70M in January 2021.

Has Driehaus Capital Management acted as a lead investor in any rounds?

According to startupim data, Driehaus Capital Management has not acted as a lead investor in any of its recorded investment rounds.

What is the most recent exit for Driehaus Capital Management?

Driehaus Capital Management had an exit in January 2024 when its portfolio company C2i Genomics was acquired by Veracyte for $95M.

In which funding stages does Driehaus Capital Management typically invest?

Driehaus Capital Management has invested in B Round and PIPE funding stages.

How many new portfolio companies did Driehaus Capital Management add in 2021?

Driehaus Capital Management added two new portfolio companies in 2021, one in January and one in April.